Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

Merkin Prize

Merkin Prize in Biomedical Technology

The Richard N. Merkin Prize in Biomedical Technology and The Merkin Family Foundation were founded by visionary health care executive Richard Merkin, MD.

Specialties

Global Health

Eligibility Requirements

Eligibility for the Merkin Prize extends to important, novel technologies that have had demonstrable clinical & real world impact on human health, such as prevention, diagnosis, or treatment, and the individuals and/or teams who were key contributors to its development. Technologies may have been created through work in academia, the commercial sector, or government. Submissions from nominators in any discipline will be considered.

For the purposes of this prize, a technology is defined as an innovation or invention of a method or device, such as a lab technique, a computational method, a medical device, or a diagnostic test. Nominations for basic discoveries, such as biological pathways, or new uses of already invented technology, will not be considered.

Each nomination must specify and demonstrate the technology’s clinical impact — past, present, and projected future. Technologies that are in either pre-clinical or clinical-trial phases of development are not eligible for the prize.

Although no formal limit has been placed on the number of individual nominees, more than four is discouraged except under exceptional conditions. If nominating a team, no more than 50 members of the team may be nominated.

In some cases, it may be desirable to use one or more of the nomination slots to propose a team of investigators whose collaborative work was key in the development of a technology. Teams in any industry are eligible to receive the Merkin Prize, and the team will allocate its cash award equally among its members if selected for a prize.

To qualify for a team nomination, the nominated technology could not have been created without the specific contributions of each team member. Eligible team members include all of those who have directly contributed to the development of the nominated technology. Those in primarily administrative roles are not eligible for the prize.

Diverse perspectives and experiences help drive transformational biomedical research. To that end, we particularly encourage nominations from historically underrepresented communities.

Current Broad Institute employees and Institute Members are ineligible to receive the Prize. Technology developed at, or in collaboration with, the Broad Institute is ineligible.

Consortia, Institutions, and/or Organizations are not eligible to receive the prize.

Self-nominations are not permitted. Nominators may submit no more than two nominations per cycle. Nominators must be an individual, not an institution or an organization.

Nominations determined not to include all living key contributors may be asked to resubmit an amended nomination for consideration in future cycles.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: Merkin Prize in Biomedical Technology

Sponsor Type:

Address: 265 Turkeysag ;Trail Suite 102; #110, Palmyra; Virginia; United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity